Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$25.8 - $39.97 $8,875 - $13,749
344 Added 4.16%
8,616 $255,000
Q2 2023

Jul 19, 2023

SELL
$20.94 - $38.01 $53,417 - $96,963
-2,551 Reduced 23.57%
8,272 $296,000
Q1 2023

May 12, 2023

BUY
$22.92 - $33.76 $12,491 - $18,399
545 Added 5.3%
10,823 $254,000
Q4 2022

Feb 10, 2023

SELL
$25.44 - $59.78 $68,891 - $161,884
-2,708 Reduced 20.85%
10,278 $280,000
Q3 2022

Nov 03, 2022

SELL
$43.66 - $61.0 $59,726 - $83,448
-1,368 Reduced 9.53%
12,986 $699,000
Q2 2022

Aug 09, 2022

SELL
$28.82 - $77.35 $99,486 - $267,012
-3,452 Reduced 19.39%
14,354 $579,000
Q1 2022

May 09, 2022

BUY
$48.25 - $100.49 $56,790 - $118,276
1,177 Added 7.08%
17,806 $1.18 Million
Q4 2021

Feb 10, 2022

BUY
$88.71 - $120.43 $254,863 - $345,995
2,873 Added 20.89%
16,629 $1.66 Million
Q3 2021

Nov 09, 2021

BUY
$98.77 - $132.17 $270,234 - $361,617
2,736 Added 24.83%
13,756 $1.72 Million
Q2 2021

Aug 05, 2021

BUY
$109.77 - $165.68 $305,599 - $461,253
2,784 Added 33.8%
11,020 $1.37 Million
Q1 2021

May 11, 2021

BUY
$127.04 - $179.1 $194,117 - $273,664
1,528 Added 22.78%
8,236 $1.26 Million
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $345,361 - $469,638
3,455 Added 106.21%
6,708 $865,000
Q3 2020

Nov 02, 2020

BUY
$80.32 - $111.8 $261,280 - $363,685
3,253 New
3,253 $364,000
Q3 2019

Oct 28, 2019

SELL
$62.59 - $110.3 $10.5 Million - $18.5 Million
-167,388 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$63.94 - $91.11 $10.7 Million - $15.3 Million
167,388 New
167,388 $14.5 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.64B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.